Cipla is recalling 7,992 bottles of its Difluprednate Ophthalmic Emulsion 0.05% (difluprednate) eye drops because the bottles may have defective closures that compromise the sterility of the medication. No incidents or injuries have been reported to date, but a loss of sterility in eye medication can lead to serious infections. These prescription eye drops were sold at pharmacies nationwide in the United States.
Defective bottle seals can allow contaminants to enter the eye drops, making the product no longer sterile. Using non-sterile eye medication poses a moderate risk of developing ocular infections, which could lead to vision loss or other permanent eye damage.
You have 2 options:
Manufactured by Cipla Ltd., India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.